Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1774353
PUBLISHER: BCC Research | PRODUCT CODE: 1774353
Digital Biomarkers: Global Markets
PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.
The global market for monitoring digital biomarkers is estimated to grow from $2.6 billion in 2025 to $9.5 billion by the end of 2030, at a CAGR of 29.7% from 2025 through 2030.
The global market for predictive digital biomarkers is estimated to grow from $920.7 million in 2025 to $3.7 billion by the end of 2030, at a CAGR of 32.3% from 2025 through 2030.
Report Scope
This report provides an overview of the global market for digital biomarkers and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030. The market is segmented based on system components, applications, therapeutic areas, end users and regions. The regions covered in this study include North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries in these regions.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and governance (ESG) developments and discusses emerging technologies related to the market.
Report Includes
- 53 data tables and 54 additional tables
- An overview of the global market for digital biomarkers
- Estimation of the market size and analyses of global market trends, with data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Information regarding major market drivers, opportunities and challenges, industry chain structure, distribution channel and technological advancements that are affecting the overall market
- Evaluation of market potential and revenue forecast for the digital biomarkers market based on system component, application, therapeutic area, end user and region
- Insights into the industry structure, current competitive scenario, R&D activities, growth strategies and ESG trends of the market
- Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, joint ventures and strategic alliances
- Profiles of the leading companies, including Actigraph LLC., AliveCor Inc., Altoida, Evidation Health Inc., and IXICO Plc.
Product Code: BIO227B
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Overview and Market Definition
- Digital Biomarker Types
- Comparison of Traditional and Digital Biomarkers
- PESTEL Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
- Impact of U.S. Tariff Laws on the Digital Biomarkers Market
- Increase in Product Costs
- Effects on Supply Chain
- Opportunities for Local Production
- Conclusion
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Rising Adoption of mHealth Apps and Wearables
- Growing Application of Digital Biomarkers in Neurodegenerative and Psychiatric Disorders
- Increasing Role of Digital Biomarkers in Clinical Trials
- Corporate Wellness Programs and Incentives
- Market Restraints
- Data Standardization and Interpretation Issues
- Difficulties in Validation of Biomarkers
- Data Privacy and Protection
- Market Opportunities
- Growing Technology Innovations
- Increasing Research Collaborations and Partnerships
Chapter 4 Regulatory Landscape
- Regulatory Scenario
- The U.S.
- Canada
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies and Developments
- Artificial Intelligence-based Digital Biomarkers
- Enhancement of Digital Biomarkers by AI and ML
- Benefits of AI-Driven Digital Biomarkers
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by System Component
- Key Takeaways
- Data Collection Tools
- Data Integration Systems
- Market Breakdown by Application
- Key Takeaways
- Diagnostic Digital Biomarkers
- Monitoring Digital Biomarkers
- Predictive Digital Biomarkers
- Other Applications
- Market Breakdown by Therapeutic Area
- Key Takeaways
- Cardiovascular and Metabolic Disorders
- Psychiatric Disorders
- Neurological Disorders
- Musculoskeletal Disorders
- Respiratory Disorders
- Other Therapeutic Areas
- Market Breakdown by End User
- Key Takeaways
- Pharmaceutical Companies and Research Institutions
- Healthcare Providers
- Patients and Caregivers
- Employers
- Payers
- Geographic Breakdown
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Key Takeaways
- Prominent Digital Biomarkers Companies
- Competitor Types and Their Strategies
- Pharmaceutical Companies
- Large Technology Companies
- Small and Medium-Size Technology Companies
- Strategic Analysis
- Agreements, Collaborations and Partnerships
- New Product Launches
- Acquisitions and Mergers
- Regulatory Approvals
Chapter 8 Sustainability in Digital Biomarkers Market: ESG Perspective
- Introduction
- Sustainability Factors
- Environmental Sustainability
- Social Sustainability
- Economic Sustainability
- Other Factors
- Scaling Sustainable Practices in Healthcare
- Business Practices Implementing Sustainable Solutions
- Conclusion
Chapter 9 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- ACTIGRAPH LLC.
- AKILI INC.
- ALIVECOR INC.
- ALTOIDA
- EMBIC CORP.
- EMPATICA INC.
- EVIDATION HEALTH INC.
- FEEL THERAPEUTICS
- HUMA
- IXICO PLC
- KINSA INC.
- KONEKSA HEALTH
- NEUROTRACK TECHNOLOGIES INC.
- VIVOSENSMEDICAL GMBH
- WINTERLIGHT LABS
Product Code: BIO227B
List of Tables
- Summary Table : Global Market for Digital Biomarkers, by Application, Through 2030
- Table 1 : Digital Biomarker Types
- Table 2 : Traditional and Digital Biomarker Comparison
- Table 3 : Digital Biomarkers Examples
- Table 4 : Technology Innovations by Digital Biomarker Companies
- Table 5 : Key Research Collaborations and Partnerships, 2023-2025
- Table 6 : Global Market for Digital Biomarkers, by System Component, Through 2030
- Table 7 : Global Digital Biomarkers Market for Data Collection Tools, by Type, Through 2030
- Table 8 : Global Digital Biomarkers Market for Data Collection Tools, by Region, Through 2030
- Table 9 : Global Digital Biomarkers Market for Mobile and Web Apps, by Region, Through 2030
- Table 10 : Global Digital Biomarkers Market for Wearables, by Region, Through 2030
- Table 11 : Global Digital Biomarkers Market for Implantables and Ingestibles, by Region, Through 2030
- Table 12 : Global Digital Biomarkers Market for Other Data Collection Tools, by Region, Through 2030
- Table 13 : Global Digital Biomarkers Market for Data Integration Systems, by Region, Through 2030
- Table 14 : Global Market for Digital Biomarkers, by Application, Through 2030
- Table 15 : Global Market for Diagnostic Digital Biomarkers, by Region, Through 2030
- Table 16 : Global Market for Monitoring Digital Biomarkers, by Region, Through 2030
- Table 17 : Global Market for Predictive Digital Biomarkers, by Region, Through 2030
- Table 18 : Global Market Other Applications of Digital Biomarkers, by Region, Through 2030
- Table 19 : Global Market for Digital Biomarkers, by Therapeutic Area, Through 2030
- Table 20 : Global Digital Biomarkers Market for Cardiovascular and Metabolic Disorders, by Region, Through 2030
- Table 21 : Global Digital Biomarkers Market for Psychiatric Disorders, by Region, Through 2030
- Table 22 : Global Digital Biomarkers Market for Neurological Disorders, by Region, Through 2030
- Table 23 : Global Digital Biomarkers Market for Musculoskeletal Disorders, by Region, Through 2030
- Table 24 : Global Digital Biomarkers Market for Respiratory Disorders, by Region, Through 2030
- Table 25 : Global Digital Biomarkers Market for Other Therapeutic Areas, by Region, Through 2030
- Table 26 : Global Market for Digital Biomarkers, by End User, Through 2030
- Table 27 : Global Digital Biomarkers Market for Pharmaceutical Companies and Research Institutions, by Region, Through 2030
- Table 28 : Global Digital Biomarkers Market for Healthcare Providers, by Region, Through 2030
- Table 29 : Global Digital Biomarkers Market for Patients and Caregivers, by Region, Through 2030
- Table 30 : Global Digital Biomarkers Market for Employers, by Region, Through 2030
- Table 31 : Global Digital Biomarkers Market for Payers, by Region, Through 2030
- Table 32 : Global Market for Digital Biomarkers, by Region, Through 2030
- Table 33 : North American Market for Digital Biomarkers, by System Component, Through 2030
- Table 34 : North American Market for Data Collection Tools, by Type, Through 2030
- Table 35 : North American Market for Digital Biomarkers, by Application, Through 2030
- Table 36 : North American Market for Digital Biomarkers, by Therapeutic Area, Through 2030
- Table 37 : North American Market for Digital Biomarkers, by End User, Through 2030
- Table 38 : North American Market for Digital Biomarkers, by Country, Through 2030
- Table 39 : European Market for Digital Biomarkers, by System Component, Through 2030
- Table 40 : European Market for Data Collection Tools, by Type, Through 2030
- Table 41 : European Market for Digital Biomarkers, by Application, Through 2030
- Table 42 : European Market for Digital Biomarkers, by Therapeutic Area, Through 2030
- Table 43 : European Market for Digital Biomarkers, by End User, Through 2030
- Table 44 : European Market for Digital Biomarkers, by Country, Through 2030
- Table 45 : Asia-Pacific Market for Digital Biomarkers, by System Component, Through 2030
- Table 46 : Asia-Pacific Market for Data Collection Tools, by Type, Through 2030
- Table 47 : Asia-Pacific Market for Digital Biomarkers, by Application, Through 2030
- Table 48 : Asia-Pacific Market for Digital Biomarkers, by Therapeutic Area, Through 2030
- Table 49 : Asia-Pacific Market for Digital Biomarkers, by End User, Through 2030
- Table 50 : Asia-Pacific Market for Digital Biomarkers, by Country, Through 2030
- Table 51 : RoW Market for Digital Biomarkers, by System Component, Through 2030
- Table 52 : RoW Market for Data Collection Tools, by Type, Through 2030
- Table 53 : RoW Market for Digital Biomarkers, by Application, Through 2030
- Table 54 : RoW Market for Digital Biomarkers, by Therapeutic Area, Through 2030
- Table 55 : RoW Market for Digital Biomarkers, by End User, Through 2030
- Table 56 : RoW Market for Digital Biomarkers, by Sub-Region, Through 2030
- Table 57 : Prominent Digital Biomarkers Companies
- Table 58 : Agreements, Collaborations and Partnerships in the Digital Biomarkers Market, 2023-2025
- Table 59 : New Product Launches in the Digital Biomarkers Market, 2022-2025
- Table 60 : Acquisitions and Mergers in the Digital Biomarkers Market, 2024 and 2025
- Table 61 : Regulatory Approvals in the Digital Biomarkers Market, 2022-2025
- Table 62 : Information Sources for this Report
- Table 63 : Abbreviations Used in this Report
- Table 64 : ActiGraph LLC.: Company Snapshot
- Table 65 : ActiGraph LLC.: Product Portfolio
- Table 66 : ActiGraph LLC.: News/Key Developments, 2023-2025
- Table 67 : Akili Inc.: Company Snapshot
- Table 68 : Akili Inc.: Product Portfolio
- Table 69 : Akili Inc.: News/Key Developments, 2024
- Table 70 : Alivecor Inc.: Company Snapshot
- Table 71 : AliveCor Inc.: Product Portfolio
- Table 72 : AliveCor Inc.: News/Key Developments, 2024 and 2025
- Table 73 : Altoida: Company Snapshot
- Table 74 : Altoida: Product Portfolio
- Table 75 : Embic Corp.: Company Snapshot
- Table 76 : Embic Corp.: Product Portfolio
- Table 77 : Empatica Inc.: Company Snapshot
- Table 78 : Empatica Inc.: Product Portfolio
- Table 79 : Empatica Inc.: News/Key Developments, 2023 and 2024
- Table 80 : Evidation Health Inc.: Company Snapshot
- Table 81 : Evidation Health Inc.: Product Portfolio
- Table 82 : Evidation Health Inc.: News/Key Developments, 2022-2024
- Table 83 : Feel Therapeutics: Company Snapshot
- Table 84 : Feel Therapeutics: Product Portfolio
- Table 85 : Feel Therapeutics: News/Key Developments, 2022 and 2023
- Table 86 : Huma: Company Snapshot
- Table 87 : Huma: Product Portfolio
- Table 88 : Huma: News/Key Developments, 2023-2025
- Table 89 : IXICO plc: Company Snapshot
- Table 90 : IXICO plc: Financial Performance, FY 2023 and 2024
- Table 91 : IXICO plc: Product Portfolio
- Table 92 : IXICO plc: News/Key Developments, 2024 and 2025
- Table 93 : Kinsa Inc.: Company Snapshot
- Table 94 : Kinsa Inc.: Product Portfolio
- Table 95 : Kinsa Inc.: News/Key Developments, 2024
- Table 96 : Koneksa Health: Company Snapshot
- Table 97 : Koneksa Health: Product Portfolio
- Table 98 : Koneksa Health: News/Key Developments, 2023 and 2024
- Table 99 : Neurotrack Technologies Inc.: Company Snapshot
- Table 100 : Neurotrack Technologies Inc.: Product Portfolio
- Table 101 : Neurotrack Technologies Inc.: News/Key Developments, 2022
- Table 102 : VivoSensMedical GmbH: Company Snapshot
- Table 103 : VivoSensMedical GmbH: Product Portfolio
- Table 104 : VivoSensMedical GmbH: News/Key Developments, 2021
- Table 105 : Winterlight Labs: Company Snapshot
- Table 106 : Winterlight Labs: Product Portfolio
List of Figures
- Summary Figure : Global Market Share of Digital Biomarkers, by Application, 2024
- Figure 1 : PESTEL Analysis: Digital Biomarkers Market
- Figure 2 : Digital Biomarkers Market Dynamics
- Figure 3 : Distribution of Clinical Trials with Digital Biomarkers as Endpoints, by Therapeutic Area
- Figure 4 : Global Market Shares of Digital Biomarkers, by System Component, 2024
- Figure 5 : Global Digital Biomarkers Market Share of Data Collection Tools, by Type, 2024
- Figure 6 : Global Digital Biomarkers Market Share of Mobile and Web Apps, by Region, 2024
- Figure 7 : Global Digital Biomarkers Market Share of Wearables, by Region, 2024
- Figure 8 : Global Digital Biomarkers Market Share of Implantables and Ingestibles, by Region, 2024
- Figure 9 : Global Digital Biomarkers Market Share of Other Data Collection Tools, by Region, 2024
- Figure 10 : Global Digital Biomarkers Market Share of Data Integration Systems, by Region, 2024
- Figure 11 : Global Market Share of Digital Biomarkers, by Application, 2024
- Figure 12 : Global Market Share of Diagnostic Digital Biomarkers, by Region, 2024
- Figure 13 : Global Market Share of Monitoring Digital Biomarkers, by Region, 2024
- Figure 14 : Global Market Share of Predictive Digital Biomarkers, by Region, 2024
- Figure 15 : Global Market Share of Other Applications of Digital Biomarkers, by Region, 2024
- Figure 16 : Global Market Share of Digital Biomarkers, by Therapeutic Area, 2024
- Figure 17 : Global Digital Biomarkers Market Share of Cardiovascular and Metabolic Disorders, by Region, 2024
- Figure 18 : Global Digital Biomarkers Market Share of Psychiatric Disorders, by Region, 2024
- Figure 19 : Global Digital Biomarkers Market Share of Neurological Disorders, by Region, 2024
- Figure 20 : Global Digital Biomarkers Market Share of Musculoskeletal Disorders, by Region, 2024
- Figure 21 : Global Digital Biomarkers Market Share of Respiratory Disorders, by Region, 2024
- Figure 22 : Global Digital Biomarkers Market Share of Other Therapeutic Areas, by Region, 2024
- Figure 23 : Global Market Share of Digital Biomarkers, by End User, 2024
- Figure 24 : Global Digital Biomarkers Market Share of Pharmaceutical Companies and Research Institutions, by Region, 2024
- Figure 25 : Global Digital Biomarkers Market Share of Healthcare Providers, by Region, 2024
- Figure 26 : Global Digital Biomarkers Market Share of Patients and Caregivers, by Region, 2024
- Figure 27 : Global Digital Biomarkers Market Share of Employers, by Region, 2024
- Figure 28 : Global Digital Biomarkers Market Share of Payers, by Region, 2024
- Figure 29 : Global Market Share of Digital Biomarkers, by Region, 2024
- Figure 30 : North American Market Share of Digital Biomarkers, by Country, 2024
- Figure 31 : U.S. Elderly* Population, 2010-2050
- Figure 32 : European Market Share of Digital Biomarkers, by Country, 2024
- Figure 33 : Asia-Pacific Market Share of Digital Biomarkers, by Country, 2024
- Figure 34 : RoW Market Share of Digital Biomarkers, by Sub-Region, 2024
- Figure 35 : Digital Biomarkers: Competitor Types and Their Strategies
- Figure 36 : Sustainability Factors in the Digital Biomarkers Industry
- Figure 37 : Scaling Sustainable Practices in Healthcare
- Figure 38 : IXICO plc: Revenue Share, by Country/Region, FY 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.